Oct 15, 2025, 12:00:00 AM
Extraction of THC and its metabolites from human nail samples using ISOLUTE® SLE+ prior to UPLC-MS/MS analysis
By Biotage
For research use only. NOT for use in diagnostic procedures.
Figure 1. Structure of Δ9-tetrahydrocannabinol (THC).
Introduction
The testing of alternative matrices in forensic and/or clinical toxicology is gaining popularity, partly due to less invasive means of collection. Matrices such as hair or nail can provide a more rounded picture of abstinence or abuse and associated timeframes.
This application note describes a procedure for sample pre-treatment and extraction of THC and its metabolites from human nail samples, using the Biotage® Lysera for matrix pulverisation, and pre-concentration of the sample prior to clean up using ISOLUTE® SLE+ supported liquid extraction.
Manual processing protocols were developed using the Biotage® Pressure+ 96 (plate format) or 48 (column format) Positive Pressure Manifolds.
This application note contains procedures optimized for both individual column format and 96-well plate format for higher throughput applications. The methodology delivers clean extracts with analyte recoveries > 70% (plate format) or > 75% (column format) with %RSD < 10% for all analytes and LLOQ as low as 20 fg/mg of nail.
ISOLUTE SLE+ Supported Liquid Extraction cartridges and plates offer an efficient alternative to traditional liquid-liquid extrac- tion (LLE) for bioanalytical sample preparation, providing high analyte recoveries, no emulsion formation and significantly reduced preparation time.
Analytes
Tetrahydrocannabinol (THC), 11-Nor-9-carboxy-Δ⁹- tetrahydrocannabinol (THC-COOH), 11-Hydroxy-Δ⁹- tetrahydrocannabinol (THC-OH), Δ9-tetrahydrocannabinolic acid-A (THCAA), cannabidiol (CBD), and cannabinol (CBN)
Internal standards
Tetrahydrocannabinol –D3 (THC- D3), 11-Nor-9-carboxy-Δ⁹- tetrahydrocannabinol-D3 (THC- COOH-D3) and 11-Hydroxy-Δ⁹- tetrahydrocannabinol- D3 (THC-OH- D3)
These were used during the calibration process and recovery work was also done alongside the standards.
Sample preparation procedure
Format
ISOLUTE® SLE+ 400 µL capacity cartridges (p/n 820-0055-B) or
ISOLUTE® SLE+ 400 µL capacity 96-well plate (p/n 820-0400-P01)
Matrix preparation
Weigh 10 mg of nail into 2 mL Biotage® Lysera tubes (p/n 19-620) containing 4 x 2.4 mm stainless steel beads (p/n 19-640).
Micropulverisation procedure
Grind to a fine powder using Biotage® Lysera (Conditions - 8 x 6.95 m/sec for 45 seconds with a 45 second dwell.)
Add 1 mL 0.1% formic acid in methanol to each nail sample. Also add 10 µL of a 10 ng/mL ISTD making a 10 pg/mg spike. Mix.
Centrifuge tubes for 10 minutes at 13,300 rpm (Heraeus Pico 17 Microcentrifuge (Thermo Scientific) with 24 position, 2 mL rotor).
Post micropulverisartion
Transfer a 250 µL aliquot of supernatant into 12 x 75 mm evaporation tubes and evaporate extracts to dryness using a TurboVap® LV at 40 °C. Reconstitute in methanol:water (80:20, v/v, 250 µL).
Supported liquid extraction conditions
|
|
ISOLUTE® SLE+ 400 µL Cartridges |
ISOLUTE® SLE+ 400 µL Plate |
|
Sample loading
|
Load up to 250 µL of reconstituted extract onto each ISOLUTE® SLE+ cartridge. A pulse of pressure is not needed as the methanolic extract flows straight onto the bed. Allow the sample to absorb for 5 minutes. |
Load up to 250 µL of reconstituted extract onto each ISOLUTE® SLE+ well. A pulse of pressure is not needed as the methanolic extract flows straight onto the bed. Allow the sample to absorb for 5 minutes. |
|
Analyte Extraction |
Apply MTBE (600 µL) allow to flow under gravity for 5 minutes. Apply a further aliquot of MTBE (600 µL) and allow to flow under gravity for 5 minutes. For complete removal apply a pulse of positive pressure at 10 psi (10–20 seconds). |
Apply MTBE (600 µL) allow to flow under gravity for 5 minutes. Apply a further aliquot of MTBE (600 µL) and allow to flow under gravity for 5 minutes. For complete removal apply a pulse of positive pressure at 10 psi (10–20 seconds). |
|
Collection Vessels |
Collect extract in 12 x 75 mm glass tubes. |
Collect extract in 96-well collection plates. |
|
Post Elution |
Evaporate extracts at 40 °C, for 30 mins at a flow rate of 1.5 L/min using a Turbovap® LV. |
Evaporate extracts at 40 °C, for 30 mins at a flow rate of 20-40 L/min using the Biotage® SPE Dry-96. |
|
Reconstitute |
Reconstitute extracts in a mix of mobile phase A/mobile phase B (80:20, v/v, 200 µL). Vortex mix, transfer into a 96-well format plate and cover with a sealing mat prior to injection. |
Reconstitute extracts in a mix of mobile phase A/mobile phase B (80:20, v/v, 200 µL). Vortex mix. Cover plate with a sealing mat prior to injection. |
UHPLC conditions
Instrument
Shimadzu Nexera X2 UHPLC
Column
Restek Pinnacle DB Biphenyl 1.9um 50 x 2.1 mm combined with a Restek EXP guard holder and biphenyl guard
Mobile phase
A: 0.01% Formic Acid (aq)
B: 0.01% Formic Acid in MeCN
Flow rate
0.7 mL/min
Table 1. UHPLC gradient.
|
Time (min) |
%A |
%B |
|
0 |
60 |
40 |
|
2.5 |
5 |
95 |
|
2.6 |
60 |
40 |
|
4.1 |
60 |
40 |
Injection volume
5 µL
Column temperature
50 °C
MS/MS conditions
Instrument
Shimadzu 8060 Triple Quadrupole MS using ES interface
Nebulizing gas flow
3 L/min
Drying gas flow
5 L/min
Heating gas flow
15 L/min
Interface temperature
400 oC
DL temperature
300 oC
Heat block temperature
500 oC
CID gas flow
270 kPa
Table 2. MS conditions for target analytes in positive mode.
|
Analytes |
MRM Transition |
Collision Energy |
|
THC-D3 |
318.0 > 196.15 |
-24 |
|
318.0 > 123.2 |
-32 |
|
|
THC |
315.0 > 193.10 |
-23 |
|
315.0 > 123.2 |
-32 |
|
|
OH-THC-D3 |
334.0 > 316.15 |
-15 |
|
334.0 > 196.25 |
-25 |
|
|
OH-THC |
331.0 > 313.3 |
-15 |
|
331.0 > 193.25 |
-26 |
|
|
THC-COOH-D3 |
346.3 > 302.3 |
22 |
|
346.3 > 248.30 |
28 |
|
|
THC-COOH |
343.3 > 299.3 |
22 |
|
343.3 > 245.25 |
30 |
|
|
CBN |
309.3 > 279.1 |
32 |
|
309.3 > 222.05 |
47 |
|
|
CBD |
315.1 > 193.1 |
-23 |
|
315.1 > 123.25 |
-35 |
|
|
THCAA |
357.3 > 313.3 |
26 |
|
357.3 > 245.25 |
33 |
Results
This simple sample preparation method delivers clean extracts and analyte recoveries mostly greater than 75% with RSDs lower than 10% for all analytes (see fig 2). LLOQs are below 10 pg/mg and as low as 20 fg/mg for THCA-A (see table 3) for ISOLUTE® SLE+ cartridge formats used.
Recoveries
Figure 2. Representative analyte recoveries.
Calibration curves
Figure 3. Calibration curves for THC (a), CBN (b) and THCA-A (c) using human nail with 400 µL capacity cartridge format (loading 250 µL of extracted sample as described).
Calibration curve performance was investigated from nails spiked between 0.01–100 pg/mg. Good linearity was observed for all analytes typically delivering r2 values greater than 0.999. Table 3. details linearity performance and associated LOQ for each analyte using both ISOLUTE® SLE+ formats.
Table 3. Analyte calibration curve r2 and LOQ performance.
|
Analyte |
r2 |
LLOQ (pg/mg) |
r2 |
LLOQ (pg/mg) |
|
Column Format |
Plate Format |
|||
|
THC |
0.9997 |
5 |
0.9998 |
10 |
|
OH-THC |
0.9997 |
5 |
0.9998 |
10 |
|
THC-COOH |
0.9995 |
1 |
0.9997 |
1 |
|
CBN |
0.9995 |
1 |
0.9992 |
1 |
|
CBD |
0.9992 |
1 |
0.9992 |
1 |
|
THCAA |
0.9995 |
0.02 |
0.9997 |
0.05 |
Chemicals and reagents
- Methanol (LC-MS grade), Acetonitrile (Gradient MS) were purchased from Honeywell Research Chemicals (Bucharest, Romania).
- All analyte standards and deuterated internal standards, and acetic acid (99.7%) (LC-MS grade) were purchased from Sigma-Aldrich Company Ltd. (Gillingham, UK).
- Water used was 18.2 MOhm-cm, drawn daily from a Direct-Q5 water purifier.
- Mobile phase A (0.01% Formic acid aq) was prepared by adding 50 µL acid to 500 mL of purified water.
- Mobile phase B (0.01% Formic acid in acetonitrile) was prepared by adding 50 µL acid to 500 mL of HPLC grade acetonitrile.
- Internal standards (10 pg/mg) were prepared from a 1 ng/µL stock solution by adding 10 µL of each of to 970 µL of MeOH. This makes a 10 ng/mL stock and then 10 µL of this solution was added to each calibration sample.
Additional information
- All data shown in this application note was generated using various fingernail samples, provided by healthy human volunteers.
- THC and some of its metabolites bind to plastic, so in order to increase recoveries and reduce RSDs the pre-concentration evaporation steps should always be performed in glass tubes.
- Biotage®Lysera hints and tips
- A minimum of four tubes must be loaded in the tube carriage to ensure balance during processing.
- Ensure vial caps are firmly tightened and Lysera locking mechanism is fully engaged.
- To minimize sample transfer and manipulation steps, 2 mL Lysera tubes were placed directly into the centrifuge (Heraeus Pico 17 Microcentrifuge (Thermo Scientific) with 24 position, 2 mL rotor).
Conclusion
This application note demonstrates that ISOLUTE®SLE+ cartridges or plates can be used in conjunction with Biotage® Lysera to provide a simple but effective sample preparation procedure for determination of THC and metabolites from human nail samples.
Ordering information
|
Part Number |
Description |
Quantity |
|
19-060 |
Biotage® Lysera |
1 |
|
19-649 |
2 mL Reinforced Tubes with Screw Caps (Bulk pack) |
1000 |
|
19-640 |
2.4 mm Metal Beads 500 grams |
1 |
|
820-0055-B |
ISOLUTE 400 µL Sample Volume Cartridges |
50 |
|
820-0400-P01 |
ISOLUTE SLE+ 400 µL Capacity Plate |
1 |
|
PPM-96 |
Biotage® PRESSURE+ 96 Positive Pressure Manifold |
1 |
|
PPM-48 |
Biotage® PRESSURE+ 48 Positive Pressure Manifold |
1 |
|
415000 |
TurboVap® LV |
1 |
|
SD-9600-DHS-EU |
Biotage® SPE Dry 96 Sample Concentrator system 220/240V |
1 |
|
SD-9600-DHS-NA |
Biotage® SPE Dry 96 Sample Concentrator system 100/120V |
1 |
|
121-5203 |
Collection Plate, 2 mL Square |
50 |
|
121-5204 |
Piercable Sealing Mat |
50 |
|
C44651 |
Test Tubes (12 x 75 mm, Uncap) |
1000 |
Literature Number: AN929
Published: Dec 7, 2025 6:00:00 AM